D-TAX Sterile Dry Injection contains Cefotaxime Sodium IP precisely equivalent to 125mg anhydrous cefotaxime, representing a premium third-generation cephalosporin antibiotic manuf...

D-TAX Sterile Dry Injection contains Cefotaxime Sodium IP precisely equivalent to 125mg anhydrous cefotaxime, representing a premium third-generation cephalosporin antibiotic manufactured under stringent aseptic conditions. This sterile formulation ensures maximum therapeutic efficacy and patient safety while maintaining compliance with Indian Pharmacopoeia standards. The product is specifically designed for reconstitution with sterile water for injection, providing healthcare professionals with a reliable antibacterial solution for serious infections where immediate intervention is required. Its consistent quality and sterility assurance make it a preferred choice for medical institutions seeking effective infection control solutions that deliver predictable clinical results across diverse patient populations.

This antibiotic injection finds extensive application across multiple healthcare sectors including general hospitals, specialized clinics, surgical centers, and emergency care facilities. It serves critical therapeutic roles in internal medicine departments, general surgery units, pediatric care, and intensive care settings for treating both gram-positive and gram-negative bacterial infections. The pharmaceutical distribution industry values D-TAX for its regulatory compliance and consistent performance in various clinical applications. Medical wholesalers and distributors regularly stock this product due to its high demand in treating respiratory infections, urinary tract complications, and postoperative infections across different healthcare environments and patient demographics.

D-TAX delivers exceptional value through its proven reliability, consistent quality standards, and demonstrated effectiveness in infection treatment protocols. The manufacturing process ensures batch-to-batch consistency, significantly reducing treatment variability while enhancing patient outcomes through predictable antibiotic performance. Healthcare providers trust D-TAX for its rapid bactericidal action, favorable safety profile, and compatibility with various treatment regimens, making it an essential component of medical inventories for managing serious bacterial infections. The product's stability and sterility maintenance throughout its shelf life further contribute to its reputation as a dependable therapeutic option in critical healthcare scenarios.

Key Features:
- Contains Cefotaxime Sodium IP equivalent to 125mg anhydrous cefotaxime per vial
- Manufactured under strict aseptic conditions ensuring complete product sterility
- Complies with Indian Pharmacopoeia quality standards and specifications
- Third-generation cephalosporin antibiotic with broad-spectrum antibacterial coverage
- Designed for easy reconstitution with sterile water for immediate administration

Benefits:
- Provides effective treatment for serious bacterial infections requiring rapid intervention
- Ensures consistent therapeutic performance through stringent quality control measures
- Offers reliable sterility maintenance throughout product shelf life and usage
- Delivers broad-spectrum coverage against both gram-positive and gram-negative bacteria
- Supports healthcare professionals in achieving positive patient outcomes through predictable efficacy